Regular VEGF Inhibitor Dosing Better in Macular Degeneration – Medscape

Medscape
This finding comes from a post hoc analysis of anatomic and functional outcomes in the second year of the Vascular Endothelial Growth Factor Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (VIEW) studies

and more

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment